General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | 1.03 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | 1.06 | 1.12 | 0.06 | 5.66% |
2023-11-02 | 2023-09 | 1.01 | 1.04 | 0.03 | 2.97% |
2023-08-03 | 2023-06 | 1.06 | 1.06 | N/A | N/A |
2023-05-04 | 2023-03 | 1.02 | 1.02 | N/A | N/A |
2023-02-23 | 2022-12 | 0.88 | 0.98 | 0.1 | 11.36% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-06 | Oppenheimer | Upgrade | Perform | Perform |
2023-06-29 | Hovde Group | Upgrade | Market Perform | Outperform |
2023-05-08 | RBC Capital | Upgrade | Outperform | |
2023-05-07 | Oppenheimer | Upgrade | Perform | |
2023-02-27 | Truist Securities | Upgrade | Hold | |
2023-02-26 | B. Riley Securities | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-31 | BEAUVAIS JASON B | General Counsel | 175.83K | Stock Award(Grant) |
2024-03-31 | HYZAK DWAYNE L | Chief Executive Officer | 522.82K | Stock Award(Grant) |
2023-04-30 | JACKSON JOHN EARL | Director | 65.78K | Stock Award(Grant) |
2023-04-30 | LANE BRIAN E | Director | 35.69K | Stock Award(Grant) |
2024-03-31 | MAGDOL DAVID L | President | 474.48K | Stock Award(Grant) |
2024-03-31 | MESERVE NICHOLAS T | Officer | 96.42K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Price (T.Rowe) Associates Inc | 3.40M | 136.27M | 4.13% |
2023-06-29 | Burgundy Asset Management Ltd. | 999.45K | 40.01M | 1.21% |
2023-06-29 | Morgan Stanley | 758.84K | 30.38M | 0.92% |
2023-06-29 | Van Eck Associates Corporation | 716.26K | 28.67M | 0.87% |
2023-06-29 | Legal & General Group PLC | 580.40K | 23.23M | 0.70% |
2023-06-29 | T. Rowe Price Investment Management, Inc. | 492.31K | 19.71M | 0.60% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Price (T.Rowe) Mid-Cap Value Fund | 2.05M | 81.99M | 2.48% |
2023-06-29 | Price (T.Rowe) Mid-Cap Value Equity Trust | 939.99K | 37.63M | 1.14% |
2023-09-29 | VanEck ETF Trust -VanEck BDC Income ETF | 800.76K | 32.53M | 0.97% |
2023-06-29 | Price (T.Rowe) Small-Cap Value Fund | 325.73K | 13.04M | 0.40% |
2023-05-30 | John Hancock Fds II-Mid Value Fund | 217.14K | 8.61M | 0.26% |
2023-06-29 | Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 160.57K | 6.43M | 0.19% |
Dividend | Date |
---|---|
0.24 | 2024-06-06 |
0.24 | 2024-05-07 |
0.24 | 2024-04-05 |
0.3 | 2024-03-19 |
0.24 | 2024-03-07 |
0.24 | 2024-02-07 |
Good results but just cashed out. Capital gain is more than the equivalent of the next 20 dividend payouts. Will jump back in again soon.
Running high into earnings…
MAIN has a dividend yield 11% higher than it’s five year average, and a solid forward P/E ratio.
This stock is NOT overvalued…if anything it is undervalued.
Add to this the fact that it has never lowered it’s dividend, not through two recessions.
Earnings beat!!!!!
Way too high.
Fake surge. Going lower. Be patient. April will be a suffering month. Wait for numbers. Instead of buying the rumor and selling the fact, buy the fact.
Wait for $10. If my memory is correct they have stopped their dividend once before.
$$$NSPX. Possible treatment for Covid19
https://microcapdaily.com/the-inside-scoop-on-inspyr-therapeutics-inc-otcmkts-nspx/125607/
Way too high. Good to buy at 29
Way too expensive! This should drop to 30 quickly. I think fair value is 27. The low I see is 23.16. Would love to buy there.